User Stats

Level: Guru
Member Since: 16/02/2022

Profile Information

First name Heiko
Last name Ott
I have professional experience in:

Business angel, Corporate investor, Funding sources, Fundraising, Institutional investor, Professional investor, Seed funding, Venture capital, Bioinformatics, Biotech, Digital Health, Drug Delivery, Drug Discovery, Food tech, Genomics, Health tech, Immunology, Medical Device, Nanotechnology, Neurosciences, Oncology, Personalised medicine, Predictive medicine, Therapeutics, Wearables, Business strategy, Market access, Regulatory, Startups, Technology transfer, medical big data and analytics, regenerative medicine, diagnostic devices, ophthalmic devices, antibodies, cell therapy, gene therapy, molecular diagnostics, small molecules, Finance & accounting, IP & Licensing, ai

Help us confirm that you're an expert

Business and corporate development professional with a focus on biopharma and life science companies from start-up financing to multiple exits via IPO and M&A. Successfully executed M&A transactions include the acquisitions of Biotie/Elbion by Acorda Therapeutics, Wavelight by Alcon/Novartis and Xenios by Fresenius. Initial public offerings were achieved after Series A investments and board support to IntegraGen [ALINT] at EURONEXT and Pieris Pharmaceuticals [PIRS] at NASDAQ. Business and corporate development projects at Eleva, faceALS, Protagen Protein Services, Seleon, SchwarzerCardiotek and Resuscitec. Entrepreneurial activities and business creation at DiSCoV2eR, EWARN, Enginears, Fusix, Neurevo, Invitris, Meno and Plectonic as well as advisor for EIT Health, early stage family offices, iGEM competition, Roland Berger and Jury Member at Roche’s Future X Healthcare Award. Leadership and experience in developing novel start-up companies from breakthrough science at leading academic institutions. Active solution-oriented style, enthusiasm inspiring team members, and excellent networking capabilities as well as passion to transform cutting-edge innovation into leading biopharma and life science companies.

LinkedIn

http://www.linkedin.com/in/heikoott

Base
Name

Heiko Ott

I have professional experience in:

Business angel, Corporate investor, Funding sources, Fundraising, Institutional investor, Professional investor, Seed funding, Venture capital, Bioinformatics, Biotech, Digital Health, Drug Delivery, Drug Discovery, Food tech, Genomics, Health tech, Immunology, Medical Device, Nanotechnology, Neurosciences, Oncology, Personalised medicine, Predictive medicine, Therapeutics, Wearables, Business strategy, Market access, Regulatory, Startups, Technology transfer, medical big data and analytics, regenerative medicine, diagnostic devices, ophthalmic devices, antibodies, cell therapy, gene therapy, molecular diagnostics, small molecules, Finance & accounting, IP & Licensing, ai

Help us confirm that you're an expert

Business and corporate development professional with a focus on biopharma and life science companies from start-up financing to multiple exits via IPO and M&A. Successfully executed M&A transactions include the acquisitions of Biotie/Elbion by Acorda Therapeutics, Wavelight by Alcon/Novartis and Xenios by Fresenius. Initial public offerings were achieved after Series A investments and board support to IntegraGen [ALINT] at EURONEXT and Pieris Pharmaceuticals [PIRS] at NASDAQ. Business and corporate development projects at Eleva, faceALS, Protagen Protein Services, Seleon, SchwarzerCardiotek and Resuscitec. Entrepreneurial activities and business creation at DiSCoV2eR, EWARN, Enginears, Fusix, Neurevo, Invitris, Meno and Plectonic as well as advisor for EIT Health, early stage family offices, iGEM competition, Roland Berger and Jury Member at Roche’s Future X Healthcare Award. Leadership and experience in developing novel start-up companies from breakthrough science at leading academic institutions. Active solution-oriented style, enthusiasm inspiring team members, and excellent networking capabilities as well as passion to transform cutting-edge innovation into leading biopharma and life science companies.

LinkedIn

http://www.linkedin.com/in/heikoott